https://www.selleckchem.com/products/r16.html
Although acellular dermal matrix (ADM) is widely used in expander-implant-based breast reconstructions, previous analyses have been unable to demonstrate improvements in patient-reported outcomes (PROs) with this approach over non-ADM procedures. This study aims to develop a more selective, evidence-based approach to the use of ADM in expander-implant-based breast reconstruction by identifying patient subgroups in which ADM improved clinical outcomes and PROs. The Mastectomy Reconstruction Outcomes Consortium Study prospectively evaluated i
Me gusta
Comentario
Compartir
